Literature DB >> 20477588

Insight into the inflammasome and caspase-activating mechanisms.

Olivier Gaide1, Hal M Hoffman.   

Abstract

Inflammasomes are recently discovered molecular complexes that can sense danger signals and specifically activate caspase-1 and -5 and proinflammatory cytokines (IL-1beta and IL-18). Upon signaling, the inflammasome complex forms around a NOD-like receptor family member that serves both as a danger sensor and as a recruiting platform. The number of known triggers that stimulate inflammasomes is rapidly rising, ranging from genetic mutations to microbial products, gout crystals, ultraviolet light and adjuvant chemicals. As a result of this surprising diversity, the inflammasome may have a significant impact on most medical fields. A good understanding of the molecular mechanisms underlying its activation/regulation is essential today, as several therapeutic and diagnostic tools have already reached the bedside, and more are sure to come.

Entities:  

Year:  2008        PMID: 20477588     DOI: 10.1586/1744666X.4.1.61

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  3 in total

1.  Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2.

Authors:  Venugopal Rajanbabu; Lakshmi Galam; Jutaro Fukumoto; Juan Enciso; Pratima Tadikonda; Troy N Lane; Sayantani Bandyopadhyay; Prasanna Tamarapu Parthasarathy; Young Cho; Seong Ho Cho; Yong Chul Lee; Richard F Lockey; Narasaiah Kolliputi
Journal:  Cell Immunol       Date:  2015-06-16       Impact factor: 4.868

Review 2.  Initial immunopathogenesis of multiple sclerosis: innate immune response.

Authors:  Norma Y Hernández-Pedro; Guillermo Espinosa-Ramirez; Verónica Pérez de la Cruz; Benjamín Pineda; Julio Sotelo
Journal:  Clin Dev Immunol       Date:  2013-09-24

3.  Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.

Authors:  Hailong Zhang; Xi Chen; Beibei Zong; Hongmin Yuan; Zhizeng Wang; Yinxiang Wei; Xuance Wang; Guangchao Liu; Jun Zhang; Shulian Li; Guanchang Cheng; Yaohui Wang; Yuanfang Ma
Journal:  J Cell Mol Med       Date:  2018-07-11       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.